DataSheet1_A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy.docx
Chemoresistance is a major therapeutic obstacle in the treatment of breast cancer. Therefore, how to overcome chemoresistance is a problem to be solved. Here, a glutathione (GSH)/cathepsin B (CB) dual-controlled nanomedicine formed by cyclic disulfide-bridged peptide (cyclic-1a) as a potent anticancer agent is reported. Under the sequential treatment of GSH and CB, cyclic-1a can efficiently self-assemble into nanofibers. In vitro studies show that cyclic-1a promotes the apoptosis of MCF-7/DOX cells by inducing the cleavages of caspase-3 and PARP. In vivo studies confirm that cyclic-1a significantly inhibits the progression of MCF-7/DOX cells-derived xenograft in nude mice, with no obvious adverse reactions. This study provides a paradigm of GSH/CB dual-controlled nanomedicine for high-efficacy and low-toxic DOX-resistant breast cancer therapy.
History
References
- https://doi.org//10.1002/adma.201605021
- https://doi.org//10.1016/j.addr.2016.08.006
- https://doi.org//10.1038/ncomms13190
- https://doi.org//10.1083/jcb.201804161
- https://doi.org//10.3390/cells9102204
- https://doi.org//10.1038/onc.2013.395
- https://doi.org//10.1039/c6cs00013d
- https://doi.org//10.1038/s41467-019-09587-y
- https://doi.org//10.1002/adma.202003134
- https://doi.org//10.1002/adfm.201806058
- https://doi.org//10.1016/j.nantod.2016.02.004
- https://doi.org//10.1016/j.jcis.2011.09.006
- https://doi.org//10.1039/c7sc03338a
- https://doi.org//10.1016/j.nano.2009.12.006
- https://doi.org//10.3390/biom10101429
- https://doi.org//10.1039/c5sm02039e
- https://doi.org//10.2174/1568026615666150605120456
- https://doi.org//10.1073/pnas.1904979116
- https://doi.org//10.1021/bm1005195
- https://doi.org//10.1021/ja503710n
- https://doi.org//10.1038/s41388-019-0926-z
- https://doi.org//10.1039/c8nh00276b
- https://doi.org//10.1021/acsnano.8b06400
- https://doi.org//10.1016/j.compbiomed.2021.104391
- https://doi.org//10.1021/acsomega.8b00347
- https://doi.org//10.1038/nchem.1123
- https://doi.org//10.1039/c3cc41794h
- https://doi.org//10.1016/j.eururo.2020.06.034
- https://doi.org//10.1021/nn204530r
- https://doi.org//10.1073/pnas.0912124107
- https://doi.org//10.1016/j.jconrel.2011.03.017
- https://doi.org//10.1016/j.biomaterials.2020.120347
- https://doi.org//10.1016/j.jconrel.2018.11.032
- https://doi.org//10.1002/anie.201608504
- https://doi.org//10.1039/d0cc00153h
- https://doi.org//10.3322/caac.21660
- https://doi.org//10.1021/jp060425t
- https://doi.org//10.1038/onc.2008.59
- https://doi.org//10.1002/anie.201504761
- https://doi.org//10.1161/circresaha.119.314681
- https://doi.org//10.1016/j.addr.2016.04.008
- https://doi.org//10.1039/c9tb02130b
- https://doi.org//10.1177/2472630318777759
- https://doi.org//10.1158/0008-5472.Can-11-2759
- https://doi.org//10.1016/j.actbio.2019.12.016
- https://doi.org//10.1039/b915765b
- https://doi.org//10.1002/adfm.201904969
- https://doi.org//10.1039/B611255B
- https://doi.org//10.1021/acs.bioconjchem.6b00099
- https://doi.org//10.1002/adhm.202002197
CC BY 4.0